Edit
Laurus Bio (Formerly Richcore Lifesciences)
https://www.laurus.bio/Last activity: 25.05.2026
Active
Laurus Bio (formerly Richcore Lifesciences) is an integrated research-driven biomanufacturing organization with over 15 years of experience in precision fermentation and recombinant DNA technology. We have a unique history and experience developing and manufacturing ultra-pure animal-free recombinant products for the biopharma industry and high-volume industrial-scale biotechnology products for food, health, nutrition and personal care markets.
We manufacture animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements that are safe, virus-free, and sustainable. Our products and solutions cater to the unique requirements of various industries such as Stem Cells and Regenerative Medicine, Vaccines and Biological Drugs, Cultured Meat, and Cell-Culture Media Manufacturing.
In addition, we offer in-depth fermentation-based product development and manufacturing expertise, as a service (CDMO) to novel protein companies and bio-manufacturers — from clone development, strain engineering, process development, and scale-up to large-scale commercial manufacturing, supporting our customers at every step of the microbial precision fermentation value chain.
By harnessing the power of precision fermentation and synthetic biology, we are paving the way for a global shift away from animal-derived products and making medicines and food, safer and more sustainable.
Laurus Bio’s corporate goals are aligned with the goals of the society at large to achieve meaningful and sustainable economic development. Laurus Bio intrinsically believes that doing well happens by doing good!
We manufacture animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements that are safe, virus-free, and sustainable. Our products and solutions cater to the unique requirements of various industries such as Stem Cells and Regenerative Medicine, Vaccines and Biological Drugs, Cultured Meat, and Cell-Culture Media Manufacturing.
In addition, we offer in-depth fermentation-based product development and manufacturing expertise, as a service (CDMO) to novel protein companies and bio-manufacturers — from clone development, strain engineering, process development, and scale-up to large-scale commercial manufacturing, supporting our customers at every step of the microbial precision fermentation value chain.
By harnessing the power of precision fermentation and synthetic biology, we are paving the way for a global shift away from animal-derived products and making medicines and food, safer and more sustainable.
Laurus Bio’s corporate goals are aligned with the goals of the society at large to achieve meaningful and sustainable economic development. Laurus Bio intrinsically believes that doing well happens by doing good!
Location: India, Karnataka, Bengaluru
Employees: 201-500
Investors 2
| Date | Name | Website |
| - | Unreasonab... | unreasonab... |
| 23.01.2025 | Eight Road... | eightroads... |
Mentions in press and media 3
| Date | Title | Description |
| 25.05.2026 | StrainX Bioworks nets $13m to scale biomanufacturing platform: ‘India is going to be the fermentation capital of the world’ | Indian startup StrainX Bioworks has raised $13 million to scale a precision fermentation platform producing high-value nutritional and flavor ingredients as it prepares to enter its commercialization phase. The round was led by Prime Ventur... |
| 24.03.2026 | 🎥 Future Food-Tech: Big ideas, hard truths, and the path to scale | At Future Food-Tech in San Francisco last week, we spoke to key stakeholders on everything from crossing biomanufacturing’s valley of death to the Institute of Food Technologists’ new AI-powered CoDeveloper platform to speed up the product ... |
| 21.02.2024 | Aleph Farms partners with BBGI, Fermbox Bio in Thailand as part of ‘step-by-step de-risking process’ for cultivated meat | Israeli startup Aleph Farms has teamed up with biomanufacturing specialists BBGI and Fermbox Bio to produce cultivated meat in Thailand as part of its ‘asset-light’ growth strategy. Construction of the facility, which will have a capacity o... |